Jazz Pharmaceuticals PLC (JAZZ)
Total asset turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 4,068,950 | 3,834,200 | 3,659,370 | 3,094,240 | 2,363,570 |
| Total assets | US$ in thousands | 12,012,300 | 11,393,400 | 10,835,300 | 12,298,600 | 6,535,900 |
| Total asset turnover | 0.34 | 0.34 | 0.34 | 0.25 | 0.36 |
December 31, 2024 calculation
Total asset turnover = Revenue ÷ Total assets
= $4,068,950K ÷ $12,012,300K
= 0.34
Jazz Pharmaceuticals PLC's total asset turnover has exhibited fluctuating trends over the past five years. The ratio decreased from 0.36 in 2020 to 0.25 in 2021, indicating a decline in the company's efficiency in generating sales from its total assets. However, there was a slight improvement in 2022 as the total asset turnover increased to 0.34. This improvement was sustained in 2023 and 2024, where the total asset turnover remained steady at 0.34. Overall, Jazz Pharmaceuticals PLC's total asset turnover suggests that the company may have faced challenges in effectively utilizing its assets to generate revenue in the past but has shown some improvement in recent years.
Peer comparison
Dec 31, 2024